Elevated Apo-B levels reflect an increased concentration of atherogenic particles, which can promote inflammation, endothelial dysfunction, and impaired insulin signaling, contributing to the pathogenesis of T2DM. This evidence concerns the gene INS and endothelial dysfunction.